Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-01-18

FDA Approved: LEVOTHYROXINE SODIUM — Original Application (XLCare Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved the original application for levothyroxine sodium from XLCare Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVOTHYROXINE SODIUM (levothyroxine sodium)

Snippet

ORIG AP for LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)